ID: ALA5281547

Max Phase: Preclinical

Molecular Formula: C7H5BrN2OS

Molecular Weight: 245.10

Associated Items:

Representations

Canonical SMILES:  Nc1nc2c(O)cc(Br)cc2s1

Standard InChI:  InChI=1S/C7H5BrN2OS/c8-3-1-4(11)6-5(2-3)12-7(9)10-6/h1-2,11H,(H2,9,10)

Standard InChI Key:  BDPNQSDLTBROFQ-UHFFFAOYSA-N

Associated Targets(Human)

Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 245.10Molecular Weight (Monoisotopic): 243.9306AlogP: 2.35#Rotatable Bonds: 0
Polar Surface Area: 59.14Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.02CX Basic pKa: 3.74CX LogP: 2.43CX LogD: 1.90
Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.75Np Likeness Score: -0.95

References

1. Vaidergorn MM, da Silva Emery F, Ganesan A..  (2021)  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).,  64  (19.0): [PMID:34591474] [10.1021/acs.jmedchem.1c00787]

Source